Financial Data and Key Metrics Changes - Total net revenues for Q1 2025 increased by 7.8% to RMB 833.5 million from RMB 773.4 million in the prior year period, primarily due to a 47.7% year-over-year increase in net revenues from skincare brands [15][21] - Gross profit for Q1 2025 increased by 9.7% to RMB 659.1 million from RMB 600.9 million, with gross margin rising to 79.1% from 77.7% [15][16] - The net loss for Q1 2025 was RMB 5.6 million, a significant improvement from RMB 124.9 million in the prior year, resulting in a net loss margin of 0.7% compared to 16.1% [21][22] Business Line Data and Key Metrics Changes - Skincare brands achieved a remarkable revenue growth of 47.7% year-over-year, while color cosmetics brands saw a decline of 9.9% [15][21] - Selling and marketing expenses as a percentage of total net revenues decreased to 66.4% from 69.7%, reflecting more strategic marketing spending [18][19] - General and administrative expenses as a percentage of total net revenues decreased to 7.8% from 18.1%, attributed to lower share-based compensation and reduced headcount [19] Market Data and Key Metrics Changes - The beauty market in China saw a modest growth of 3.2% year-over-year in retail sales, slightly trailing the 4.6% growth in total retail sales of consumer goods [5][6] - Online beauty sales mirrored this trend, with combined beauty sales on Q1 and Douyin recording low double-digit year-over-year growth [6] Company Strategy and Development Direction - The company is focused on accelerating growth for skincare brands and optimizing cost structures to prepare for profitable growth [7][14] - A new share repurchase program was approved, allowing the company to repurchase up to RMB 30 million worth of ordinary shares over the next 24 months, indicating confidence in future potential [13][14] - Continued investment in R&D is emphasized as a core competitive advantage, with a global R&D center in Shanghai receiving accreditation [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed encouragement regarding the progress made in executing strategic transformation despite complex market conditions [14] - For Q2 2025, the company expects total net revenues to be between RMB 810.4 million and RMB 889.9 million, representing a year-over-year increase of approximately 2% to 12% [22] Other Important Information - The company hosted an offline event to launch an upgraded product, enhancing brand awareness through targeted marketing efforts [9][10] - The company is committed to scientific research, having launched an acne research fund project that has reached over 20,000 doctors [11] Q&A Session Summary Question: How does the company plan to promote new products of Perfect Diary and Ganik? - The company emphasizes product innovation and efficacy as key drivers for consumer repeat purchases, with strong initial feedback on new products [25][26] Question: How is the performance of the June 18 shopping festival so far? - Management indicated that it is still early to predict overall performance, but initial sales are in line with expectations [28]

First Quarter 2025 Investor Presentation Yatsen Holding Limited Disclaimer This presentation has been prepared by Yatsen Holding Limited (the "Company") solely for information purpose. By viewing or accessing the information contained in this material, you hereby acknowledge and agree that no representations, warranties or undertakings, express or implied, are made by the Company or any of its directors, shareholders, employees, agents, affiliates, advisors or representatives as to, and no reliance should b ...

Core Insights - The company reported a revenue increase to 830 million yuan in Q1 2025, representing a year-on-year growth of 7.8%, continuing its growth trend [2] - The skincare segment, including brands Galénic, DR.WU, and EVELOM, saw a net income increase of 58%, contributing to a 47.7% growth in skincare revenue, totaling 360 million yuan [2] - The skincare segment accounted for 43.5% of total revenue, maintaining over 30% for 12 consecutive quarters [2] - Gross profit increased by 9.7% year-on-year, with a gross margin rising to 79.1%, marking a historical high for the quarter [2] - The company achieved a Non-GAAP net profit of 7.14 million yuan, marking two consecutive quarters of positive revenue growth and profitability [2] - The company emphasizes R&D as a core strategy for future growth, with Q1 2025 R&D investment nearing 22.64 million yuan, and a cumulative investment of over 580 million yuan since 2020 [2] Market Analysis - Analysts view the Q1 performance as a strong start, with strategic transformation yielding results, laying a solid foundation for stable growth throughout the year [3] - The company projects Q2 2025 total revenue between 810 million and 890 million yuan, indicating a year-on-year growth of approximately 2% to 12% [3] - The board has approved a new stock repurchase plan, allowing for the buyback of up to 30 million USD in common stock over the next 24 months, reflecting management's confidence in the company's long-term prospects [3]

Core Viewpoint - Yatsen Holding Limited reported a 7.8% year-over-year increase in total net revenues for Q1 2025, driven by significant growth in skincare brands despite a challenging beauty market [3][4][6]. Financial Performance - Total net revenues for Q1 2025 reached RMB 833.5 million (US$ 114.9 million), up from RMB 773.4 million in the same period last year [4][6]. - Skincare brands contributed RMB 362.4 million (US$ 49.9 million) in net revenues, marking a 47.7% increase year-over-year [6]. - Gross profit increased by 9.7% to RMB 659.1 million (US$ 90.8 million), with gross margin rising to 79.1% from 77.7% [4][6]. Operating Expenses - Total operating expenses decreased by 8.6% to RMB 693.2 million (US$ 95.5 million) compared to the prior year [5][7]. - Selling and marketing expenses were RMB 553.8 million (US$ 76.3 million), with a decrease in percentage of total net revenues to 66.4% from 69.7% [7]. - General and administrative expenses dropped to RMB 64.9 million (US$ 8.9 million), representing 7.8% of total net revenues, down from 18.1% [7][8]. Loss and Income Metrics - The company recorded a net loss of RMB 5.6 million (US$ 0.8 million), significantly reduced from RMB 124.9 million a year ago [6][11]. - Non-GAAP net income for Q1 2025 was RMB 7.1 million (US$ 1.0 million), compared to a non-GAAP net loss of RMB 83.8 million in the previous year [12][36]. Cash Flow and Balance Sheet - As of March 31, 2025, Yatsen had cash and short-term investments totaling RMB 1.28 billion (US$ 176.4 million) [13]. - Net cash generated from operating activities was RMB 23.8 million (US$ 3.3 million), a turnaround from net cash used in operating activities of RMB 121.8 million in the prior year [13]. Business Outlook - For Q2 2025, Yatsen expects total net revenues to be between RMB 810.4 million and RMB 889.9 million, indicating a year-over-year increase of approximately 2% to 12% [14]. Share Repurchase Program - The company has initiated a new share repurchase program allowing for the repurchase of up to US$ 30.0 million worth of ordinary shares over the next 24 months [15][16].

Group 1 - The core viewpoint is that the high sales expenses in the daily chemical skincare industry significantly erode profits, leading to high gross margins but low net margins [1][3] - In 2024, over half of the selected companies in the daily chemical skincare industry have a sales expense ratio exceeding 40%, indicating that they allocate more than 40% of their revenue to marketing [1] - Yatsen E-commerce has the highest sales expense ratio at 60.1%, followed by Shangmei Co. and Marubi Biotechnology with ratios of 58.11% and 55.04% respectively [1] Group 2 - Many listed companies in the daily chemical skincare industry invest heavily in marketing while underinvesting in research and development, leading to severe product homogeneity and insufficient innovation [3] - The heavy reliance on marketing has resulted in a price war within the industry, which diminishes profitability and creates a vicious cycle [3] - Companies like Betaini have become overly dependent on a single brand, with over 90% of their main business revenue coming from the "Winona" brand, which has seen a sales decline of 5.45% in 2024 [3] Group 3 - The challenge for many companies in the daily chemical skincare industry in 2025 will be to balance marketing and research and development expenditures, transitioning from a marketing-driven approach to a product-driven one [4]

Core Insights - The analysis focuses on the financial performance of 17 representative listed companies in the daily chemical skincare industry, highlighting the significant disparity between sales gross margin and net profit margin [1][2]. Group 1: Financial Performance - In 2024, nearly 80% of the selected companies reported a sales gross margin exceeding 50%, with some companies achieving gross margins over 75% [1][2]. - The industry shows a trend of high gross margins but low net profit margins, with 70% of companies having net profit margins below 15% [1][2]. - The top three companies in terms of sales gross margin are Jinbo Biological (92.02%), Juzhi Biological (82.09%), and Fulejia (81.73%) [2]. Group 2: Sales Net Margin Analysis - The leading companies in sales net margin are Jinbo Biological (50.68%), Juzhi Biological (37.22%), and Fulejia (32.78%) [4]. - Companies such as Jiaheng Household Chemicals (-2.57%), Shanghai Household Chemicals (-14.67%), and Yixian E-commerce (-20.9%) exhibit significantly low net profit margins [4]. Group 3: Industry Challenges - The high sales expenses in the daily chemical skincare industry are identified as a primary reason for the low net profit margins, as substantial marketing costs erode profits [2]. - Qing Song Co. has the lowest sales gross margin at 17.42%, attributed to its positioning as an OEM, facing intense competition from thousands of domestic cosmetic OEMs [6]. - Yixian E-commerce's negative net profit margin of -20.9% is linked to ongoing losses and high marketing expenditures [6].

Core Insights - The performance of the daily chemical skincare industry in 2024 is generally pessimistic, with only 6 out of 17 selected companies achieving both revenue and net profit growth [1][2][4] - Notably, 4 companies reported losses, including Yatsen E-commerce, Jiaheng Cosmetics, Furuida, and Shanghai Jahwa, with Yatsen E-commerce experiencing continuous losses since its IPO in 2020, totaling over 6.5 billion yuan in losses [1][2][4] Revenue and Profit Analysis - Among the 17 companies analyzed, 6 companies reported a decline in both revenue and net profit, including Qingsong Co., Kesi Co., Shuiyang Co., Furuida, and Huaxi Biological [4][5] - The companies with revenue and net profit growth include Jinbo Biological (revenue up 84.92%, net profit up 144.27%), Shangmei Co. (revenue up 62.1%), and Juzi Biological (revenue up 57.2%) [2][7][9] - Companies with revenue but no profit growth include Lafang Co. (revenue 889 million yuan, net profit down 36.84%), Beitaini (revenue 5.736 billion yuan, net profit down 33.53%), and Fulejia (revenue 2.017 billion yuan, net profit down 11.77%) [2][4] Losses Overview - Yatsen E-commerce reported total revenue of 3.393 billion yuan, a slight decline of 0.63%, with a net profit loss of 710 million yuan [5][6] - Shanghai Jahwa's revenue was 5.679 billion yuan, down 13.93%, with a net profit loss of 833 million yuan, marking a significant decline of 266.6% [5][6] - Jiaheng Cosmetics reported revenue of 923 million yuan, down 9.13%, with a net profit loss of 24 million yuan, a decline of 159% [5][6] Performance Rankings - The top three companies in revenue growth are Jinbo Biological, Shangmei Co., and Juzi Biological, with growth rates of 84.92%, 62.1%, and 57.2% respectively [7] - The bottom three in revenue growth are Shanghai Jahwa, Furuida, and Jiaheng Cosmetics, with declines of 13.93%, 13.02%, and 9.13% respectively [7] - In terms of net profit growth, the top three are Jinbo E-commerce, Shangmei Co., and Juzi Biological, with growth rates of 144.27%, 74%, and 42.4% respectively [9]

Core Insights - The performance of domestic beauty companies in China is showing significant divergence, with some achieving remarkable growth while others face declines, indicating a reshaping of the market landscape [1][4][42] Group 1: Company Performance - Proya has become the first domestic beauty company to enter the 10 billion yuan club, with a revenue of 10.778 billion yuan, growing by 21.04% [2] - Other companies like Shangmei and Juzi Biological also reported substantial revenue increases of 62.08% and 57.17% respectively, while Shanghai Jahwa experienced a revenue decline of 13.93% [2][3] - Six beauty companies have revenues exceeding 5 billion yuan, suggesting that this threshold will soon become a significant benchmark for the top 10 domestic beauty brands [1] Group 2: Profitability Trends - Juzi Biological leads in profitability with a profit of 2.062 billion yuan, up 42.06%, while Proya's profit reached 1.552 billion yuan, growing by 30% [3] - In contrast, Shanghai Jahwa reported a loss of 833 million yuan, marking a 266.60% decline, highlighting the stark differences in profitability among companies [3][11] Group 3: Market Dynamics - The current market dynamics indicate a shift towards efficacy-driven products, with companies that successfully launched standout products seeing better performance [4][5] - The competition is intensifying, with new entrants emerging and established brands needing to adapt to changing consumer preferences and market trends [7][30] Group 4: R&D and Strategic Focus - Companies are increasingly focusing on R&D, with most reporting a rise in R&D expenditures, indicating a strategic shift towards innovation and efficacy [20][21] - The trend of acquisitions and investments in technology is becoming a key strategy for companies aiming to enhance market share and scale [23][24] Group 5: Emerging Opportunities - The male skincare market is growing rapidly, presenting new opportunities for brands to capture this segment [36] - The aging population is creating demand for products targeting older consumers, which remains largely untapped [39] - As online sales plateau, brands are shifting focus to offline channels, indicating a potential new battleground for market share [40]

Core Viewpoint - Yatsen Holding Limited, a leading beauty group based in China, is set to release its unaudited financial results for Q1 2025 on May 16, 2025, before U.S. market opening [1]. Financial Results Announcement - The financial results will be discussed in a conference call scheduled for May 16, 2025, at 7:30 A.M. U.S. Eastern Time [2]. - The call can be accessed via multiple toll-free numbers for the U.S., international, and Mainland China listeners [2]. Company Overview - Yatsen Holding Limited was founded in 2016 and has launched and acquired several beauty brands, including Perfect Diary, Little Ondine, and DR.WU [3]. - Perfect Diary is recognized as one of the leading color cosmetics brands in China based on retail sales value [3]. - The company engages with customers through both online and offline channels, maintaining a strong presence across major e-commerce and social platforms in China [3].

Market Capitalization Overview - The market capitalizations of various companies are listed, with notable figures including 74.11 billion, 88.55 billion, and 76.47 billion [2] - Companies such as SON, VIPS, and TAL have market caps of 72.19 billion, 60.28 billion, and 55.72 billion respectively [2] Stock Performance - Stock price changes are highlighted, with SON showing a decrease of 0.95 (-1.99%) while VIPS increased by 0.15 (+0.85%) [2] - Other companies like TAL and Lufax also experienced minor fluctuations, with TAL decreasing by 0.04 (-0.49%) and Lufax increasing by 0.96 (+3.75%) [2] Additional Company Insights - Companies such as Huya and Yatsen have market caps of 8.06 billion and 3.27 billion respectively, with stock price changes of -0.03 (-0.77%) and 0.00 (0.00%) [2] - The performance of companies like New Oxygen and Huami Technology is also noted, with market caps of 83.07 million and 37.63 million, showing no change in stock price [3] Summary of Smaller Companies - Smaller companies like Tuniu and Cheetah Mobile have market caps of 1.08 billion and 1.17 billion respectively, with Tuniu experiencing a slight decrease of -0.01 (-1.20%) [3] - The market cap of Baosheng E-commerce is reported at 2.02 billion, with a stock price increase of 0.17 (+5.18%) [3]